These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38300900)

  • 21. Vaccine-induced HIV seropositivity: a problem on the rise.
    Van Braeckel E; Koutsoukos M; Bourguignon P; Clement F; McNally L; Leroux-Roels G
    J Clin Virol; 2011 Apr; 50(4):334-7. PubMed ID: 21300566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in the HIV-1 envelope glycoprotein can broadly rescue blocks at multiple steps in the virus replication cycle.
    Van Duyne R; Kuo LS; Pham P; Fujii K; Freed EO
    Proc Natl Acad Sci U S A; 2019 Apr; 116(18):9040-9049. PubMed ID: 30975760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The hidden cost of genetic resistance to HIV-1.
    Luban J
    Nat Med; 2019 Jun; 25(6):878-879. PubMed ID: 31160816
    [No Abstract]   [Full Text] [Related]  

  • 24. Three cases of transient HIV-1 seropositivity observed in 10 years of practice of a national HIV confirmatory laboratory.
    Tarján V; Ujhelyi E; Kellner R; Králl G; Gyuris A; Mihály I; Füst G
    AIDS; 1998 Jan; 12(1):120-1. PubMed ID: 9456268
    [No Abstract]   [Full Text] [Related]  

  • 25. Perspectives of Saskatchewan researchers and community members on HIV-1 strains circulating in Saskatchewan.
    Chelico L; King A; Ticknor J; McDonald M; Rosenes R; Mercredi J; Saddleback J; Bailey G; King M;
    AIDS; 2020 Nov; 34(13):1987-1989. PubMed ID: 32132362
    [No Abstract]   [Full Text] [Related]  

  • 26. Cohort Profile Update: The Bissau HIV Cohort-a cohort of HIV-1, HIV-2 and co-infected patients.
    Dutschke A; Jespersen S; Medina C; Nanque JP; Rodrigues A; Wejse C; Hønge BL; Jensen MM;
    Int J Epidemiol; 2023 Aug; 52(4):e232-e240. PubMed ID: 37196333
    [No Abstract]   [Full Text] [Related]  

  • 27. Recent HIV infection testing algorithms.
    Murugavel KG; Thakar M; Mehendale S
    Indian J Med Res; 2020 Sep; 152(3):181-183. PubMed ID: 33107480
    [No Abstract]   [Full Text] [Related]  

  • 28. Delayed HIV-1 seroconversion after antiretroviral therapy.
    Apetrei C; Tamalet C; Edlinger C; Damond F; Descamps D; Saimot AG; Brun-Vézinet F; Simon F
    AIDS; 1998 Oct; 12(14):1935-6. PubMed ID: 9792400
    [No Abstract]   [Full Text] [Related]  

  • 29. COVID-19 vaccination and HIV-1 acquisition.
    Logunov DY; Livermore DM; Ornelles DA; Bayer W; Marques E; Czerkinsky C; Dolzhikova IV; Ertl HC
    Lancet; 2022 Apr; 399(10333):e34-e35. PubMed ID: 35397866
    [No Abstract]   [Full Text] [Related]  

  • 30. Clearance of HIV-1 viraemia after seroconversion.
    Clementi M; Bagnarelli P; Menzo S; Valenza A; Manzin A; Varaldo PE
    Lancet; 1993 Jan; 341(8840):315-6. PubMed ID: 8093963
    [No Abstract]   [Full Text] [Related]  

  • 31. Serum eosinophil cationic protein (ECP) in human immunodeficiency virus (HIV) infection.
    Paganelli R; Fanales-Belasio E; Scala E; Carmini D; Mezzaroma I; Pinter E; Aiuti F
    J Allergy Clin Immunol; 1991 Sep; 88(3 Pt 1):416-8. PubMed ID: 1890272
    [No Abstract]   [Full Text] [Related]  

  • 32. Time course of antigenaemia and seroconversion in infants with vertically acquired HIV-1 infection.
    de Rossi A; Ometto L; Mammano F; Zanotto C; del Mistro A; Giaquinto C; Chieco-Bianchi L
    AIDS; 1993 Nov; 7(11):1528-9. PubMed ID: 8280423
    [No Abstract]   [Full Text] [Related]  

  • 33. How universal does universal test and treat have to be?
    Baggaley RF; Hollingsworth TD
    Lancet HIV; 2020 May; 7(5):e306-e308. PubMed ID: 32061316
    [No Abstract]   [Full Text] [Related]  

  • 34. [What is the patient's HIV status?].
    Christiansen CB
    Ugeskr Laeger; 2000 May; 162(20):2912. PubMed ID: 10860440
    [No Abstract]   [Full Text] [Related]  

  • 35. Protection from HIV-1 infection by HIV-2.
    Travers KU; Eisen GE; Marlink RG; Essex ME; Hsieh CC; Mboup S; Kanki PJ
    AIDS; 1998 Jan; 12(2):224-5. PubMed ID: 9468377
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunosilent HIV-1 infection: intrigue continues.
    Koup RA; Ho DD
    AIDS; 1991 Oct; 5(10):1263. PubMed ID: 1786155
    [No Abstract]   [Full Text] [Related]  

  • 37. Antibodies to recombinant HIV-1 nef protein detected in HIV-1 infection as well as in nonrisk individuals.
    Dis Markers; 1990; 8(4):226-7. PubMed ID: 1708319
    [No Abstract]   [Full Text] [Related]  

  • 38. Atypical presentation of HIV seroconversion illness in a young woman.
    Aldeen T; Mantell J
    Int J STD AIDS; 2002 Feb; 13(2):131-2. PubMed ID: 11839169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hepatitis C, HIV infection and delay in diagnosis].
    Alastrué Loscos JI; Giner Valero M
    Aten Primaria; 2002 Dec; 30(10):666; author reply 666-7. PubMed ID: 12525350
    [No Abstract]   [Full Text] [Related]  

  • 40. Frequency of subclinical visceral leishmaniasis in HIV-1-infected patients in Spain.
    Pineda JA; Hernández-Quero J; Gallardo JA; López-Ruz MA; Martínez-Pérez MA; Macías J; Lissen E
    Eur J Clin Microbiol Infect Dis; 1996 Mar; 15(3):263-4. PubMed ID: 8740869
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.